236 related articles for article (PubMed ID: 34497835)
1. Bioinformatics and Immune Infiltration Analyses Reveal the Key Pathway and Immune Cells in the Pathogenesis of Hypertrophic Cardiomyopathy.
Zhang XZ; Zhang S; Tang TT; Cheng X
Front Cardiovasc Med; 2021; 8():696321. PubMed ID: 34497835
[No Abstract] [Full Text] [Related]
2. Identification of the Immune Status of Hypertrophic Cardiomyopathy by Integrated Analysis of Bulk- and Single-Cell RNA Sequencing Data.
Zhao W; Wu T; Zhan J; Dong Z
Comput Math Methods Med; 2022; 2022():7153491. PubMed ID: 36238494
[TBL] [Abstract][Full Text] [Related]
3. Identification and verification of promising diagnostic biomarkers in patients with hypertrophic cardiomyopathy associate with immune cell infiltration characteristics.
Zheng X; Yang Y; Huang Fu C; Huang R
Life Sci; 2021 Nov; 285():119956. PubMed ID: 34520765
[TBL] [Abstract][Full Text] [Related]
4. Unveiling Immune Infiltration Characterizing Genes in Hypertrophic Cardiomyopathy Through Transcriptomics and Bioinformatics.
Gong J; Shi B; Yang P; Khan A; Xiong T; Li Z
J Inflamm Res; 2024; 17():3079-3092. PubMed ID: 38774444
[TBL] [Abstract][Full Text] [Related]
5. Identification of key genes for hypertrophic cardiomyopathy using integrated network analysis of differential lncRNA and gene expression.
Cao J; Yuan L
Front Cardiovasc Med; 2022; 9():946229. PubMed ID: 35990977
[TBL] [Abstract][Full Text] [Related]
6. Identification and Verification of Feature Biomarkers Associated With Immune Cells in Dilated Cardiomyopathy by Bioinformatics Analysis.
Zhu T; Wang M; Quan J; Du Z; Li Q; Xie Y; Lin M; Xu C; Xie Y
Front Genet; 2022; 13():874544. PubMed ID: 35646094
[No Abstract] [Full Text] [Related]
7. Identification of Potential Diagnostic Biomarkers and Biological Pathways in Hypertrophic Cardiomyopathy Based on Bioinformatics Analysis.
Yu T; Huang Z; Pu Z
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328083
[TBL] [Abstract][Full Text] [Related]
8. Dysfunctional network of hub genes in hypertrophic cardiomyopathy patients.
Wu S; Ud Din I; Sadiq FM; Abdel-Maksoud MA; Haris M; Mubarak A; Farrag MA; Alghamdi S; Almekhlafi S; Akram M; Li G
Am J Transl Res; 2022; 14(12):8918-8933. PubMed ID: 36628247
[TBL] [Abstract][Full Text] [Related]
9. Identification and verification of IGFBP3 and YTHDC1 as biomarkers associated with immune infiltration and mitophagy in hypertrophic cardiomyopathy.
Li Y; Zhang W; Dai Y; Chen K
Front Genet; 2022; 13():986995. PubMed ID: 36267414
[No Abstract] [Full Text] [Related]
10. Identification of Three Significant Genes Associated with Immune Cells Infiltration in Dysfunctional Adipose Tissue-Induced Insulin-Resistance of Obese Patients via Comprehensive Bioinformatics Analysis.
Zhai M; Luan P; Shi Y; Li B; Kang J; Hu F; Li M; Du L; Zhou D; Jian W; Peng W
Int J Endocrinol; 2021; 2021():8820089. PubMed ID: 33564304
[TBL] [Abstract][Full Text] [Related]
11. Exploring the Communal Pathogenesis, Ferroptosis Mechanism, and Potential Therapeutic Targets of Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy
Wang Z; Xia Q; Su W; Cao M; Sun Y; Zhang M; Chen W; Jiang T
Front Cardiovasc Med; 2022; 9():824756. PubMed ID: 35282347
[TBL] [Abstract][Full Text] [Related]
12. Identification and Verification of Feature Immune-Related Genes in Patients With Hypertrophic Cardiomyopathy Based on Bioinformatics Analyses.
Zheng X; Liu G; Huang R
Front Cardiovasc Med; 2021; 8():752559. PubMed ID: 34765659
[No Abstract] [Full Text] [Related]
13. Identification and validation of pyroptosis-related genes as potential biomarkers for hypertrophic cardiomyopathy: A comprehensive bioinformatics analysis.
Tang X; Shen Y; Lu Y; He W; Nie Y; Fang X; Cai J; Si X; Zhu Y
Medicine (Baltimore); 2024 Jan; 103(4):e36799. PubMed ID: 38277535
[TBL] [Abstract][Full Text] [Related]
14. Identification of biomarkers correlated with hypertrophic cardiomyopathy with co-expression analysis.
Chen R; Ge T; Jiang W; Huo J; Chang Q; Geng J; Shan Q
J Cell Physiol; 2019 Dec; 234(12):21999-22008. PubMed ID: 31059139
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility Modules and Genes in Hypertrophic Cardiomyopathy by WGCNA and ceRNA Network Analysis.
Sun Y; Xiao Z; Chen Y; Xu D; Chen S
Front Cell Dev Biol; 2021; 9():822465. PubMed ID: 35178407
[No Abstract] [Full Text] [Related]
16. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
17. Dysfunctional Network and Mutation Genes of Hypertrophic Cardiomyopathy.
Cui Y; Liu C; Luo J; Liang J
J Healthc Eng; 2022; 2022():8680178. PubMed ID: 35126952
[TBL] [Abstract][Full Text] [Related]
18. Integrative bioinformatics analysis of potential therapeutic targets and immune infiltration characteristics in dilated cardiomyopathy.
Yang Y; Liu P; Teng R; Liu F; Zhang C; Lu X; Ding Y
Ann Transl Med; 2022 Mar; 10(6):348. PubMed ID: 35433958
[TBL] [Abstract][Full Text] [Related]
19. Identification of Underlying Hub Genes Associated with Hypertrophic Cardiomyopathy by Integrated Bioinformatics Analysis.
Ma Z; Wang X; Lv Q; Gong Y; Xia M; Zhuang L; Lu X; Yang Y; Zhang W; Fu G; Ye Y; Lai D
Pharmgenomics Pers Med; 2021; 14():823-837. PubMed ID: 34285551
[TBL] [Abstract][Full Text] [Related]
20. Role of ferroptosis and immune infiltration in intervertebral disc degeneration: novel insights from bioinformatics analyses.
Liu XW; Xu HW; Yi YY; Zhang SB; Wang SJ
Front Cell Dev Biol; 2023; 11():1170758. PubMed ID: 37736497
[No Abstract] [Full Text] [Related]
[Next] [New Search]
